Philab Holdings Corp. Financial Data

Company name:Philab Holdings CorpStatus:Active
End of fiscal year:December 31 2016ISINPHY6900R1015
Year established:2000Company sector name:Healthcare
Trading currency:PHPIndustry name:Diagnostics & Research
Place of incorporation:Philippines (PH)Industry group nameMedical Diagnostics & Research
Doing business in:Philippines (PH)Address1128 38th Avenue
8th Floor, Fort Bonifacio Global City, 1634
Tel.:+63 25519639City/Country:Taguig City, Philippines
Fax:+63 28977732Web address:http://www.philab.com
Company description:Philab Holdings Corp is a holding company. It is engaged in operating in the healthcare and education sector, by supplying life science equipment to the healthcare, pharmaceutical, semiconductor, and food/beverage industries.
Price Price change [%] Bid Offer Open High Low Volume
5.20  +0.00[+0.00%] 5.02 5.38 5.02 5.34 5.02 19,900
Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
323.835512 2062.27606 - -0.04 - -130.00 - 4.03 - 9.13

DNA KEY FIGURES (at previous day's close)

Yesterday's Close
5.20
PE Ratio
-130
Market Capitalisation
323.84M
Latest Shares Outstanding
2.06B
Earnings pS (EPS)
-0.04
Dividend pS (DPS)
0.00
Dividend Yield
-
Sales per Employee
-
Effective Tax Rate
-
Foreign Sales
-
Domestic Sales
-
Selling, General & Adm/tive (SG...
-
Research & Devlopment (R&D) as ...
-
Gross Profit Margin
-
EBITDA Margin
-
Pre-Tax Profit Margin
-
Assets Turnover
-
Return on Assets (ROA)
-0.03%
Return on Equity (ROE)
-0.09%
Return on Capital Invested (ROC...
-0.09%
Current Ratio
1.21
Leverage Ratio (Assets/Equity)
5.86%
Interest Cover
-
Total Debt/Equity (Gearing Rati...
-
LT Debt/Total Capital
-
Working Capital pS
0.42
Cash pS
2.38
Book-Value pS
0.42
Tangible Book-Value pS
-
Cash Flow pS
-0.03
Free Cash Flow pS
-0.03
Spread
0.36
Gross gearing
82.95%
Net Debt
-21.98M

DNA Balance Sheet Chart (December 31 2016)

:liab eq:assets
Period † High Low
1 Week5.484.20
1 Month6.004.03
3 Months6.304.03
6 Months7.954.03
1 Year9.134.03
3 Years9.134.03
5 Years9.134.03

Share price performance previous 3 years

Share price performance intraday

Period † Open Open Avg. VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week5.305.135.1519k5M1M-0.10-1.89%
1 Month6.005.385.1819k5M336k-0.80-13.33%
3 Months6.205.765.6613k5M302k-1.00-16.13%
6 Months7.946.306.1113k5M230k-2.74-34.51%
1 Year7.876.316.2613k5M247k-2.67-33.93%
3 Years7.876.316.2613k5M247k-2.67-33.93%
5 Years7.876.316.2613k5M247k-2.67-33.93%

DNA Growth Ratios (December 31 2016)

1 year 3 years 5 years 10 years
Diluted EPS growth
-
-
-
-
Diluted continuous EPS growth
-
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
-
-0.10
-0.10
-
Revenue growth
-
-
-
-
Operating income growth
-
-
-
-
Net income growth
-
-
-
-
Net income cont growth
-
-
-
-
CFO growth
-
-
-
-
FCF growth
-
-
-
-
Operating revenue growth
-
-
-
-

DNA Income Statement December 31 2016 (PHP)

Total Revenue
0.00
Operating Revenue
0.00
Gross Profit
0.00
Cost of Revenue
0.00
Operating Expenses
1.533675
Selling,General and Administr...
1.003433
General and Administrative Ex...
1.003433
Rent and Landing Fees
0.00
Administrative Expense
0.00
General Expense
0.00
Selling and Marketing Expense
0.00
Selling Expense
0.00
Marketing Expense
0.00
Depreciation and Amortization
0.00
Depreciation
0.00
Special Income/Charges
0.00
Impairment of Capital Assets
0.00
Write Off
0.00
Interest Income/Expense,Net-O...
-952.00
Other Operating Expenses
0.52929
Staff Costs
0.00
Other Staff Costs
0.00
Operating Income
-1.180111
Other Operating Income, Total
0.353564
Miscellaneous Other Operating...
0.353564
Other Non-Operating Income/Ex...
0.00
Pretax Income
-1.180111
Provision for Income Tax
1.335551
Net Income Available to Commo...
-2.515662
Net Income
-2.515662
Net Income Including Noncontr...
-2.515662
Net Income from Continuing Op...
-2.515662
Basic EPS
-0.04
Basic EPS from Continuing Ope...
-0.04
Diluted EPS
-0.04
Diluted EPS from Continuing O...
-0.04
Basic Weighted Average Shares...
62.27606
Diluted Weighted Average Shar...
62.27606
Net Interest Income
-952.00
Net Income from Continuing an...
-2.515662
Normalized Income
-2.515662
Basic EPS,Continuing and Disc...
-0.04
Diluted EPS,Continuing and Di...
-0.04
Dividend Per Share
0.00
Net Income from Continuing Op...
-2.515662
Earning Before Interest Tax D...
-1.180111
Cost of Revenue,Reconciled
0.00
Depreciation,Reconciled
0.00
Earning Before Interest and T...
-1.180111
TotalUnusualItems
0.00
TotalUnusualItemsExcludingGoo...
0.00
Tax rate for calculations
0.30
Calculated Tax Effect Of Unus...
0.00
Normalized Basic EPS
-0.04
Normalized Diluted EPS
-0.04

DNA Efficency Ratios (December 31 2016)

Days in sales
-
Days in inventory
-
Days in payment
-
Cash conversion cycle
-
Receivable turnover
-
Inventory turnover
-
Payable turnover
-
Fixed assets turnover
-
Assets turnover
-
ROE
-0.09
ROA
-0.03
ROIC
-0.09
FCF sales ratio
-
FCF net income ratio
-
Capital expenditure sales ratio
-

DNA Financial Health Ratios (December 31 2016)

Current ratio
1.21
Quick ratio
1.20
Debt total capital ratio
-
Debt equity ratio
-
Financial leverage
5.86
Total debt to equity
-

DNA Avearge Growth Ratios Over 5 Years (December 31 2016)

Growth ann capital spending
-
Growth ann gross profit
-
Avg gross margin
-
Avg post tax margin
-
Avg pre tax marginr
-
Avg net profit
-
Avg ret commonr
-
Avg ret assets
-
Avg ret invested capital
-

DNA Profitability Ratios (-)

Gross margin
-
Operating margin
-
EBT margin
-
Tax rate
-
Net margin
-
Sales per employee
-
EBIT margin
-
EBITDA margin
-
Normalized net profit margin
-
Interest coverage
-
Inc per employee tot ops
-

DNA Valuation Ratios (December 29 2016)

Sales per share
-0.00
Growth ann sales per share 5 ye...
-
Book value per share
0.45
CF per share
-0.03
Price to EPS
1,111.11
Ratio PE 5 year high
10,925.00
Ratio PE 5 year low
131.25
Price to book
20.24
Price to sales
-
Price to cash flow
-
Price to free cash flow
-
Div rate
-
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
0.00
Sustainable growth rate
0.02
Cash return
-

DNA Balance Sheet December 31 2016 (PHP)

Total Assets
152.559584
Current Assets
152.559584
Cash,Cash Equivalents,and Sho...
148.523534
Cash and Cash Equivalents
148.523534
Cash
148.523534
Short Term Investments
0.00
Other Current Assets
0.558742
Trade and Other Receivables, ...
3.477308
Total Non-Current Assets
0.00
Deferred Taxes,Non-Current As...
0.00
Total Liabilities
126.546495
Current Liabilities
126.546495
Payables
126.546495
Other Current Liabilities
0.00
Total Non-Current Liabilities
0.00
Total Equity
26.013089
Stockholder's Equity
26.013089
Capital Stock
15.569015
Retained Earnings
-3.484401
Additional Paid in Capital
13.928475
Other Equity Interest
0.00
Total Liabilities Inc MI
126.546495
Total Non-Current Liabilities...
0.00
Total Capitalization
26.013089
Common Stock Equity
26.013089
Ordinary Shares Number
62.27606
Net Tangible Assets
26.013089
Working Capital
26.013089
Invested Capital
26.013089
Tangible Book Value
26.013089
Total Equity
26.013089

DNA Cash Flow December 31 2016 (PHP)

Cash Flow from Operating Acti...
-1.960234
Net Income from Continuing Op...
-1.180111
Total Adjustments for Non-Cas...
-0.353564
Net Foreign Currency Exchange...
0.00
Gain/Loss on Investment Secur...
0.00
Pension and Employee Benefit ...
0.00
Depreciation and Amortization
0.00
Depreciation
0.00
Other Non-Cash Items
-0.353564
Profit on Disposals
0.00
Impairment Loss/Reversal Reco...
0.00
Other Adjustments for Which C...
-0.353564
Changes in Working Capital
-0.426559
Change in Receivables
0.00
Change in Inventories
0.00
Change in Payables
-0.317614
Change in Other Current Asset...
-0.108945
Taxes Refund/Paid
0.00
Cash Flow from Investing Acti...
0.017458
Purchase/Sale of Property,Pla...
0.00
Purchase of Property,Plant an...
0.00
Sale of Property,Plant,and Eq...
0.00
Purchase/Sale of Investments,...
0.00
Sale of Investments
0.00
Other Investing Changes,Net
0.00
Interest Received, CFI
0.017458
Cash Flow from Financing Acti...
145.978592
Issuance/Payments of Debt,Net
-3.477308
Issuance/Payments of Long Ter...
-3.477308
Payments to Settle Long Term ...
-3.477308
Issuance/Payments of Common S...
125
Proceeds or Issuance of Commo...
125
Cash Dividends Paid
0.00
Other Financing Changes, Net
24.4559
Increase/Decrease in Lease Fi...
0.00
Increase in Lease Financing
0.00
Repayment in Lease Financing
0.00
Interest Paid, CFF
0.00
Cash and Cash Equivalents,End...
148.523534
Change in Cash
144.035816
Effect of Exchange Rate Chang...
0.00
Cash and Cash Equivalents,Beg...
4.487718
Issuance of Capital Stock
125
Repayment of Debt
-3.477308
Free Cash Flow
-1.960234
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Finance Manila is owned and operated by ADVFN PLC.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170820 21:01:11